AzTrials
AzTrials

Lumbar Disc HerniationNCT01363830

Short Versus Long Post-Operative Restrictions Following Lumbar Discectomy

A study testing Two-Week Post-Operative Restriction and Six-Week Post-Operative Restriction in people with Lumbar Disc Herniation, run by Brigham and Women's Hospital at 3 sites in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Post-operative restrictions following lumbar discectomy is a controversial topic. While the most widely accepted protocol restricts bending, lifting, and twisting for four to six weeks following discectomy, a number of studies support an early return to full activity without restriction. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Lumbar Disc Herniation
What is being tested?
Two-Week Post-Operative Restriction and Six-Week Post-Operative Restriction
Could I receive a placebo?
No, everyone receives an active treatment
How many people
420 participants
Where
3 sitesUnited States
Study dates
Aug 2009to Dec 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18 years of age or older
  • English speaking
  • single level lumbar disc herniation
  • surgical candidate
  • no previous lumbar surgery
  • primary radicular pain

Who cannot join

  • Less than 18 years of age
  • Non-English speaking
  • Multi-level lumbar disc herniation
  • Disc reherniation
  • Previous lumbar surgery
  • Primary low back pain

Trial locations and contacts

3 sites in 1 country.

Christopher M Bono, M.D. contact

617-732-7238

cmbono@partners.org

United States3 sites, 3 recruiting
  • Massachusetts General Hospital

    Boston, Massachusetts, 02114

    Rishabh D Phukan, 617-724-1509, rphukan@partners.org

    Krikham B. Wood, M.D.

    Recruiting
  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, 02115

    Andrew White, M.D.

    Kevin McGuire, M.D.

    Recruiting
  • Brigham & Women's Hospital

    Boston, Massachusetts, 02115

    Dana A Leonard, B.A., 617-525-8761 ext. N/A/, dleonard7@partners.org

    Christopher M Bono, M.D.

    Recruiting

Other trials in United States

About this study

Official title: Short (2-weeks) Versus Long (6-weeks) Post-Operative Restrictions Following Lumbar Discectomy: A Prospective Randomized Control Study

Post-operative restrictions following lumbar discectomy is a controversial topic. While the most widely accepted protocol restricts bending, lifting, and twisting for four to six weeks following discectomy, a number of studies support an early return to full activity without restriction. Since the goal of discectomy is to promptly provide pain relief and a return to a fully active lifestyle, perhaps post-operative restrictions are more hindering than beneficial.

Hypothesis: Post-operative restrictions following lumbar discectomy do not influence reherniation rate.

Read more

Specific Aim 1: To compare the reherniation rates between the 6-weeks of restriction and the 2-weeks of restriction groups.

Specific Aim 2: To determine the return to full activity and return to work dates of both the 6-weeks of restriction and 2-weeks of restriction groups.

Specific Aim 3: To assess the health outcomes of both the 6-weeks of restriction and 2-weeks of restriction groups.

Read the detailed description

Upon enrollment, subjects will be randomized to the "6-weeks of restriction" or "2-weeks of restriction" group. Subjects will also be asked to provide/complete:

  • demographical information
  • VAS back and leg score
  • Modified Oswestry questionnaire

All of the surgeries will be performed using a so-called limited discectomy in which the herniated disc fragment is removed without an aggressive disc space curettage. Prior to surgery, the subjects' discs will be classified by the Primary Investigator and Site Responsible Investigator on a T-2 weighted MRI according to the Carragee Disc Herniation Classification system.

The discs will be reassessed intraoperatively by the surgeon to confirm the assigned classification. In addition, a radiologist will review a random sampling set of discs on T-2 weighted MRI to eliminate bias and validate the classifications.

Subjects will be followed for a 2 year time period with study visits at 2 weeks, 6 weeks, 3 months, 1 year, and 2 years. At every follow-up visit, the following will be completed and/or documented:

  • A reherniation (any clinical symptoms of a reherniation will be verified and documented by MRI)
  • Return to full activity and/or work (date)
  • VAS back and leg score
  • Modified Oswestry questionnaire
Being tested
Two-Week Post-Operative Restriction, Six-Week Post-Operative Restriction
Keywords
Disc, lumbar, herniation
Medical subject headings
Intervertebral Disc Displacement, Hernia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Two-Week Post-Operative RestrictionBehavioural

    Surgeon recommends the patient restrict bending, lifting, and twisting for two-weeks following discectomy.

  • Six-Week Post-Operative RestrictionBehavioural

    Surgeon recommends patient restrict bending, lifting, and twisting for six-weeks following discectomy.

Study groups in NCT01363830
Study groupRoleWhat they receive
Two-Week Post-Operative RestrictionExperimentalRestrict bending, lifting, and twisting for two-weeks following discectomy.
Receives: Behavioral: Two-Week Post-Operative Restriction
Six-Week Post-Operative RestrictionActive comparatorRestrict bending, lifting, and twisting for six-weeks following discectomy.
Receives: Behavioral: Six-Week Post-Operative Restriction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reherniation Rates

    To compare the reherniation rates between the restricted and unrestricted groups.

    Measured: 2 years

Secondary outcomes (1)
  1. Activity/Health Outcomes

    To determine the return to full activity and return to work dates of both the restricted and unrestricted groups. Also, to assess the health outcomes of both the restricted and unrestricted groups.

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jun 2011 (estimated)
  2. Study startAug 2009
  3. Primary completionDec 2013 (estimated)
  4. Study completionDec 2013 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
420 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01363830
Sponsor's protocol ID
2009P001125
Status last verified
Oct 2013
First submitted
31 May 2011
Last updated
22 Oct 2013
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Two-Week Post-Operative Restriction and Six-Week Post-Operative Restriction in people with Lumbar Disc Herniation, run by Brigham and Women's Hospital at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Oct 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Dana A Leonard (617-525-8761, dleonard7@partners.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reherniation Rates (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in